Acromegaly due to ectopic GHRH secretion from a neuroendocrine tumor (NET) is rare and comprises <1% of all acromegaly cases. Herein we present a 57-year-old woman with clinical and biochemical features of acromegaly and a 6 cm pancreatic NET (pNET), secreting GHRH and calcitonin. Following surgical resection of the pancreatic tumor, IGF1, GH and calcitonin normalized, and the clinical features of acromegaly improved. In vitro studies confirmed that the tumor secreted large amounts of both GHRH and calcitonin, and incubation of pNET culture-derived conditioned media stimulated GH release from a cultured human pituitary adenoma. This is a unique case of pNET secreting both GHRH and calcitonin. The ability of the pNET-derived medium to stimulate in vitro GH release from a human pituitary-cell culture, combined with the clinical and hormonal remission following tumor resection, confirmed the ectopic source of acromegaly in this patient.
CITATION STYLE
Zornitzki, T., Rubinfeld, H., Lysyy, L., Schiller, T., Raverot, V., Shimon, I., & Knobler, H. (2016). pNET co-secreting GHRH and calcitonin: ex vivo hormonal studies in human pituitary cells. Endocrinology, Diabetes & Metabolism Case Reports, 2016. https://doi.org/10.1530/edm-15-0134
Mendeley helps you to discover research relevant for your work.